Novo Nordisk sues Eli Lilly over misleading ads; Merck licenses alimatravir; AbbVie/Genmab clarify Epkinly trial; J&J touts Talvey/Tecvayli data; MannKind gets FDA nod.
Plus news about Abbvie and Genmab, Johnson & Johnson and Mannkind.
Novo urges court to block Lilly’s GLP-1 ads: Novo Nordisk asked a New Jersey …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Novo escalates Lilly false advertising suit with planned bid to halt comparative ads
Novo escalates legal fight with Lilly; J&J reinforces ‘dominance’ in multiple myeloma
Novo Nordisk files lawsuit accusing rival Eli Lilly of running ‘false and misleading’ GLP-1 ads
Novo Nordisk sues Eli Lilly over GLP-1 drug ads it calls ‘deceptive’
Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising
Pharma heavyweights Novo Nordisk and Eli Lilly clash over anti-obesity drug ads
Novo Nordisk pursues preliminary injunction to block Eli Lilly weight-loss drug ads
Novo Nordisk sues Eli Lilly over "maliciously and deceptively false" GLP-1 ads
GLP-1 Fight: Novo Sues Eli Lilly Over Nationwide "Deceptive Advertising" Campaign
Merck stages expanded access to monthly HIV PrEP pill ahead of approval
